Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 16 (1) , 59-63
- https://doi.org/10.1038/nbt0198-59
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antisense therapeuticsCurrent Opinion in Chemical Biology, 1998
- Altered mRNA Splicing and Inhibition of Human E-selectin Expression by an Antisense Oligonucleotide in Human Umbilical Vein Endothelial CellsPublished by Elsevier ,1996
- Developing antisense oligonucleotides from the laboratory to clinical trialsDrug Discovery Today, 1996
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide librariesNucleic Acids Research, 1996
- Facilitating oligonucleotide delivery: helping antisense deliver on its promise.Proceedings of the National Academy of Sciences, 1996
- Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexesBiochemical Journal, 1995
- Intracerebroventricular Administration of AT1Receptor Antisense Oligonucleotides Inhibits the Behavioral Actions of Angiotensin IIJournal of Neurochemistry, 1994
- Characterization of angiotensin AT1A receptor isoform by its ligand binding signatureRegulatory Peptides, 1993
- Sequence‐dependent hydrolysis of RNA using modified oligonucleotide splints and RNase HFEBS Letters, 1987